Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Pericardial Approach for Cardiac Therapies: Old Practice With New Ideas

  • Han, Seong-Wook (Krannert Institute of Cardiology, Indiana University School of Medicine) ;
  • Hwang, Chun (Utah Valley Regional Medical Center)
  • Published : 2010.10.30
⟨ Previous Next ⟩

Abstract

Treatment of cardiac disease via the epicardium fell under the domain of cardiac surgery due to the need for an open thoracotomy. Since an open thoracotomy is invasive in nature and has the potential for complications, a minimally invasive and percutaneous approach would be more attractive for suitable patients. The recent success of epicardial ablation of refractory arrhythmia via the percutaneous pericardial approach has increased the potential for delivery of epicardial therapies. Epicardial ablation has increased the success and safety since anti-coagulation and transseptal catheterization for left atrial arrhythmias is not required. The pericardial space has also been used to deliver therapy for several cardiac diseases. There are reports on successful delivery of drugs and their efficacy. Even though there was a wide range of efficacies reported in those studies, the reported complication rates are strikingly low, which suggests that direct delivery of drugs to the epicardium via the pericardial space is safe. Furthermore, recent animal studies have supported the feasibility of epicardial delivery of biological agents, including genes, cells, and even genetically engineered tissue for therapeutic purposes. In conclusion, percutaneous pericardial cannulation of closed pericardial space can play a significant role in providing non-surgical therapy for cardiovascular diseases. However, it requires skills and operator experiences. Therefore, there is need to further develop new tools, safer techniques, and effective procedure environment before generalizing this procedure.

Keywords

References

  1. Sosa E, Scanavacca M, d'Avila A, Pilleggi F. A new technique to perform epicardial mapping in the electrophysiology laboratory. J Cardiovasc Electrophysiol 1996;7:531-6. https://doi.org/10.1111/j.1540-8167.1996.tb00559.x
  2. Maisch B, Karatolios K. New possibilities of diagnostics and therapy of pericarditis. Internist (Berl) 2008;49:17-26. https://doi.org/10.1007/s00108-007-1961-3
  3. Braunwald E, Libby P. Braunwald's Heart Disease:A Textbook of Cardiovascular Medicine. 7 ed. Philadelphia: Saunders;2007.
  4. Choe YH, Im JG, Park JH, Han MC, Kim CW. The anatomy of the pericardial space: a study in cadavers and patients. AJR Am J Roentgenol 1987;149:693-7. https://doi.org/10.2214/ajr.149.4.693
  5. Groell R, Schaffler GJ, Rienmueller R. Pericardial sinuses and recesses: findings at electrocardiographically triggered electron-beam CT. Radiology 1999;212:69-73. https://doi.org/10.1148/radiology.212.1.r99jl0969
  6. Levy-Ravetch M, Auh YH, Rubenstein WA, Whalen JP, Kazam E. CT of the pericardial recesses. AJR Am J Roentgenol 1985;144:707-14. https://doi.org/10.2214/ajr.144.4.707
  7. McMurdo KK, Webb WR, von Schulthess GK, Gamsu G. Magnetic resonance imaging of the superior pericardial recesses. AJR Am J Roentgenol 1985;145:985-8. https://doi.org/10.2214/ajr.145.5.985
  8. Vesely TM, Cahill DR. Cross-sectional anatomy of the pericardial sinuses, recesses, and adjacent structures. Surg Radiol Anat 1986;8:221-7. https://doi.org/10.1007/BF02425071
  9. D'Avila A, Scanavacca M, Sosa E, Ruskin JN, Reddy VY. Pericardial anatomy for the interventional electrophysiologist. J Cardiovasc Electrophysiol 2003;14:422-30. https://doi.org/10.1046/j.1540-8167.2003.02487.x
  10. Chaffanjon P, Brichon PY, Faure C, Favre JJ. Pericardial reflection around the venous aspect of the heart. Surg Radiol Anat 1997;19:17-21.
  11. Shabetai R. Function of the normal pericardium. Clin Cardiol 1999;22(1 Suppl 1):I4-5.
  12. Miyazaki T, Pride HP, Zipes DP. Prostaglandins in the pericardial fluid modulate neural regulation of cardiac electrophysiological properties. Circ Res 1990;66:163-75. https://doi.org/10.1161/01.RES.66.1.163
  13. Verrier RL, Waxman S, Lovett EG, Moreno R. Transatrial access to the normal pericardial space: a novel approach for diagnostic sampling, pericardiocentesis, and therapeutic interventions. Circulation 1998;98:2331-3. https://doi.org/10.1161/01.CIR.98.21.2331
  14. Seferovic PM, Ristic AD, Maksimovic R, et al. Initial clinical experience with PerDUCER device: promising new tool in the diagnosis and treatment of pericardial disease. Clin Cardiol 1999;22(1 Suppl 1):I30-5.
  15. Columbus M. De re Anatomica. In: Beurlaque N, ed. Vol. 15. Venice;1559.
  16. Baille M. On the want of a pericardium in the human body. Trans Soc Improve Med Chir Knowl 1793;1:91-102.
  17. Hammoudeh AJ, Kelly ME, Mekhjian H. Congenital total absence of the pericardium: case report of a 72-year-old man and review of the literature. J Thorac Cardiovasc Surg 1995;109:805-7. https://doi.org/10.1016/S0022-5223(95)70365-9
  18. Van Son JA, Danielson GK, Schaff HV, Mullany CJ, Julsrud PR, Breen JF. Congenital partial and complete absence of the pericardium. Mayo Clin Proc 1993;68:743-7. https://doi.org/10.1016/S0025-6196(12)60630-2
  19. Hano O, Baba T, Hayano M, Yano K. Congenital defect of the left pericardium with sick sinus syndrome. Am Heart J 1996;132:1293-5. https://doi.org/10.1016/S0002-8703(96)90482-2
  20. Lonsky V, Stetina M, Habal P, Markova D. Congenital absence of the left pericardium in combination with left pulmonary artery hypoplasia, right aortic arch, and secundum atrial septal defect. Thorac Cardiovasc Surg 1992;40:155-7. https://doi.org/10.1055/s-2007-1020136
  21. Lu C, Ridker PM. Echocardiographic diagnosis of congenital absence of the pericardium in a patient with VATER association defects. Clin Cardiol 1994;17:503-4. https://doi.org/10.1002/clc.4960170909
  22. Ellis K, Leeds NE, Himmelstein A. Congenital deficiencies in the parietal pericardium: a review with 2 new cases including successful diagnosis by plain roentgenography. Am J Roentgenol Radium Ther Nucl Med 1959;82:125-37.
  23. Baim RS, MacDonald IL, Wise DJ, Lenkei SC. Computed tomography of absent left pericardium. Radiology 1980;135:127-8. https://doi.org/10.1148/radiology.135.1.7360949
  24. Gutierrez FR, Shackelford GD, McKnight RC, Levitt RG, Hartmann A. Diagnosis of congenital absence of left pericardium by MR imaging. J Comput Assist Tomogr 1985;9:551-3. https://doi.org/10.1097/00004728-198505000-00026
  25. Lawler LP, Fishman EK. Pericardial varices: depiction on three-dimensional CT angiography. AJR Am J Roentgenol 2001;177:202-4. https://doi.org/10.2214/ajr.177.1.1770202
  26. Millward SF, Ramsewak W, Joseph G, Jones B, Zylak CJ. Pericardial varices demonstrated by computed tomography. J Comput Assist Tomogr 1985;9:1106-7. https://doi.org/10.1097/00004728-198511000-00019
  27. Feigin DS, Fenoglio JJ, McAllister HA, Madewell JE. Pericardial cysts: a radiologic-pathologic correlation and review. Radiology 1977;125:15-20. https://doi.org/10.1148/125.1.15
  28. Inoue S, Fujino S, Tezuka N, et al. Encapsulated pericardial fat necrosis treated by video-assisted thoracic surgery: report of a case. Surg Today 2000;30:739-43. https://doi.org/10.1007/s005950070088
  29. Stephens DA, Kocab F. Pericardial fat necrosis. J Thorac Cardiovasc Surg 1988;95:727-9.
  30. Sosa E, Scanavacca M, D'Avila A, et al. Endocardial and epicardial ablation guided by nonsurgical transthoracic epicardial mapping to treat recurrent ventricular tachycardia. J Cardiovasc Electrophysiol 1998;9:229-39. https://doi.org/10.1111/j.1540-8167.1998.tb00907.x
  31. Sosa E, Scanavacca M, d'Avila A, Oliveira F, Ramires JA. Nonsurgical transthoracic epicardial catheter ablation to treat recurrent ventricular tachycardia occurring late after myocardial infarction. J Am Coll Cardiol 2000;35:1442-9. https://doi.org/10.1016/S0735-1097(00)00606-9
  32. D'Avila A, Gutierrez P, Scanavacca M, et al. Effects of radiofrequency pulses delivered in the vicinity of the coronary arteries: implications for nonsurgical transthoracic epicardial catheter ablation to treat ventricular tachycardia. Pacing Clin Electrophysiol 2002;25:1488-95. https://doi.org/10.1046/j.1460-9592.2002.01488.x
  33. d'Avila A, Houghtaling C, Gutierrez P, et al. Catheter ablation of ventricular epicardial tissue: a comparison of standard and cooled-tip radiofrequency energy. Circulation 2004;109:2363-9. https://doi.org/10.1161/01.CIR.0000128039.87485.0B
  34. Garcia FC, Bazan V, Zado ES, Ren JF, Marchlinski FE. Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 2009;120:366-75. https://doi.org/10.1161/CIRCULATIONAHA.108.834903
  35. Schauerte P, Scherlag BJ, Pitha J, et al. Catheter ablation of cardiac autonomic nerves for prevention of vagal atrial fibrillation. Circulation 2000;102:2774-80. https://doi.org/10.1161/01.CIR.102.22.2774
  36. Zei PC, Stevenson WG. Epicardial catheter mapping and ablation of ventricular tachycardia. Heart Rhythm 2006;3:360-3. https://doi.org/10.1016/j.hrthm.2005.10.022
  37. Ayers GM, Rho TH, Ben-David J, Besch HR Jr, Zipes DP. Amiodarone instilled into the canine pericardial sac migrates transmurally to produce electrophysiologic effects and suppress atrial fibrillation. J Cardiovasc Electrophysiol 1996;7:713-21. https://doi.org/10.1111/j.1540-8167.1996.tb00579.x
  38. Baek SH, Hrabie JA, Keefer LK, et al. Augmentation of intrapericardial nitric oxide level by a prolonged-release nitric oxide donor reduces luminal narrowing after porcine coronary angioplasty. Circulation 2002;105:2779-84. https://doi.org/10.1161/01.CIR.0000017432.19415.3E
  39. Gleason JD, Nguyen KP, Kissinger KV, Manning WJ, Verrier RL. Myocardial drug distribution pattern following intrapericardial delivery: an MRI analysis. J Cardiovasc Magn Reson 2002;4:311-6. https://doi.org/10.1081/JCMR-120013304
  40. Moreno R, Waxman S, Rowe K, Verrier RL. Intrapericardial beta-adrenergic blockade with esmolol exerts a potent antitachycardic effect without depressing contractility. J Cardiovasc Pharmacol 2000;36:722-7. https://doi.org/10.1097/00005344-200012000-00006
  41. Ujhelyi MR, Hadsall KZ, Euler DE, Mehra R. Intrapericardial therapeutics: a pharmacodynamic and pharmacokinetic comparison between pericardial and intravenous procainamide delivery. J Cardiovasc Electrophysiol 2002;13:605-11. https://doi.org/10.1046/j.1540-8167.2002.00605.x
  42. Willerson JT, Igo SR, Yao SK, Ober JC, Macris MP, Ferguson JJ. Localized administration of sodium nitroprusside enhances its protection against platelet aggregation in stenosed and injured coronary arteries. Tex Heart Inst J 1996;23:1-8.
  43. Fei L, Baron AD, Henry DP, Zipes DP. Intrapericardial delivery of L-arginine reduces the increased severity of ventricular arrhythmias during sympathetic stimulation in dogs with acute coronary occlusion: nitric oxide modulates sympathetic effects on ventricular electrophysiological properties. Circulation 1997;96:4044-9. https://doi.org/10.1161/01.CIR.96.11.4044
  44. Zipes DP. Targeted drug therapy. Circulation 1990;81:1139-41. https://doi.org/10.1161/01.CIR.81.3.1139
  45. Avitall B, Hare J, Zander G, et al. Iontophoretic transmyocardial drug delivery: a novel approach to antiarrhythmic drug therapy. Circulation 1992;85:1582-93. https://doi.org/10.1161/01.CIR.85.4.1582
  46. Waxman S, Moreno R, Rowe KA, Verrier RL. Persistent primary coronary dilation induced by transatrial delivery of nitroglycerin into the pericardial space: a novel approach for local cardiac drug delivery. J Am Coll Cardiol 1999;33:2073-7. https://doi.org/10.1016/S0735-1097(99)00131-X
  47. Uchida Y, Yanagisawa-Miwa A, Nakamura F, et al. Angiogenic therapy of acute myocardial infarction by intrapericardial injection of basic fibroblast growth factor and heparin sulfate: an experimental study. Am Heart J 1995;130:1182-8. https://doi.org/10.1016/0002-8703(95)90140-X
  48. Laham RJ, Hung D, Simons M. Therapeutic myocardial angiogenesis using percutaneous intrapericardial drug delivery. Clin Cardiol 1999;22(1 Suppl 1):I6-9.
  49. Hermans JJ, van Essen H, Struijker-Boudier HA, Johnson RM, Theeuwes F, Smits JF. Pharmacokinetic advantage of intrapericardially applied substances in the rat. J Pharmacol Exp Ther 2002;301:672-8. https://doi.org/10.1124/jpet.301.2.672
  50. Leithauser B, Park JW. Cardioembolic stroke in atrial fibrillation-rationale for preventive closure of the left atrial appendage. Korean Circ J 2009;39:443-58. https://doi.org/10.4070/kcj.2009.39.11.443
  51. Friedman PA, Asirvatham SJ, Dalegrave C, et al. Percutaneous epicardial left atrial appendage closure: preliminary results of an electrogram guided approach. J Cardiovasc Electrophysiol 2009;20:908-15. https://doi.org/10.1111/j.1540-8167.2009.01465.x
  52. March KL, Woody M, Mehdi K, Zipes DP, Brantly M, Trapnell BC. Efficient in vivo catheter-based pericardial gene transfer mediated by adenoviral vectors. Clin Cardiol 1999;22(1 Suppl 1):I23-9. https://doi.org/10.1002/clc.4960221308
  53. Lau DH, Clausen C, Sosunov EA, et al. Epicardial border zone overexpression of skeletal muscle sodium channel SkM1 normalizes activation, preserves conduction, and suppresses ventricular arrhythmia: an in silico, in vivo, in vitro study. Circulation 2009;119:19-27. https://doi.org/10.1161/CIRCULATIONAHA.108.809301
  54. Cho HC, Marban E. Biological therapies for cardiac arrhythmias: can genes and cells replace drugs and devices? Circ Res 2010;106:674-85. https://doi.org/10.1161/CIRCRESAHA.109.212936

Cited by

  1. NecroX-5 suppresses sodium nitroprusside-induced cardiac cell death through inhibition of JNK and caspase-3 activation : Suppression of SNP-induced cardiac cell death vol.38, pp.6, 2010, https://doi.org/10.1002/cbin.10242
  2. Evaluation of upconverting nanoparticles towards heart theranostics vol.14, pp.12, 2019, https://doi.org/10.1371/journal.pone.0225729